Iron-induced interleukin-6 gene expression: Possible mediation through the extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways

Toxicology

Volumn 203, Issue 1-3, 2004, Pages 199-209

  Dai, Jisen ^a   Huang, Chuanshu ^a   Wu, Jing ^a   Yang, Chengfeng ^a   Frenkel, Krystyna ^a   Huang, Xi ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

activator protein 1; Activator protein 1; AP 1; c jun NH2 terminal kinases; ERKs; extracellular signal regulated kinases; IL 6; interleukin 6; Interleukin 6; Iron; JNKs; LMW; low molecular weight; MAPK; mitogen activated protein kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYTOKINE; INTERLEUKIN 6; IRON DERIVATIVE; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOTRANSFERASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; WATER;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL ACTIVITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; EPIDERMIS CELL; GENE EXPRESSION; GENETIC TRANSFECTION; LIVER CELL; MALE; MOUSE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FAMILY; RAT; SOLUBILITY;

ANIMALS; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENES, REPORTER; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HEPATOCYTES; INDICATORS AND REAGENTS; INTERLEUKIN-6; IRON; LUCIFERASES; MALE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN KINASES; RATS; RATS, LONG-EVANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 4444283611     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2004.06.009     Document Type: Article

References (37)

1. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157
2. Bassett M.L., Halliday J.W., Powell L.W. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 6:1986;24-29
3. Beetz A., Peter R.U., Oppel T., Kaffenberger W., Rupee R.A., Meyer M., van Beuningen D., Kind P., Messer G. NF-kappaB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells. Int. J. Radiat. Biol. 76:2000;1443-1453
4. Bonkovsky H.L. Iron and the liver. Am. J. Med. Sci. 301:1991;32-43
5. Bradbear R.A., Bain C., Siskind V., Schofield F.D., Webb S., Axelsen E.M., Halliday J.W., Bassett M.L., Powell L.W. Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J. Natl. Cancer Inst. 75:1985;81-84
6. Brown K.E., Knudsen C.A. Oxidized heme proteins in an animal model of hemochromatosis. Free Radic. Biol. Med. 24:1998;239-244
7. Comporti M., Signorini C., Buonocore G., Ciccoli L. Iron release, oxidative stress and erythrocyte ageing(2) (3). Free Radic. Biol. Med. 32:2002;568-576
8. Ding M., Shi X., Dong Z., Chen F., Lu Y., Castranova V., Vallyathan V. Freshly fractured crystalline silica induces activator protein-1 activation through ERKs and p38 MAPK. J. Biol. Chem. 274:1999;30611-30616
9. Dong G., Chen Z., Li Z.Y., Yeh N.T., Bancroft C.C., Van Waes C. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res. 61:2001;5911-5918
10. Dong Z., Birrer M.J., Watts R.G., Matrisian L.M., Colburn N.H. Blocking of tumor promoter-induced AP-1 activity inhibits induced transformation in JB6 mouse epidermal cells. Proc. Natl. Acad. Sci. U.S.A. 91:1994;609-613
11. Friedman S.L. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275:2000;2247-2250
12. Hirano, T., 1998. Interleukin-6. In: Thomson, A. (Ed.), The Cytokine Handbook, third ed. Academic Press, New York, pp. 197-228.
13. Hsu T.C., Young M.R., Cmarik J., Colburn N.H. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic. Biol. Med. 28:2000;1338-1348
14. Huang C., Ding M., Li J., Leonard S.S., Rojanasakul Y., Castranova V., Vallyathan V., Ju G., Shi X. Vanadium-induced nuclear factor of activated T cells activation through hydrogen peroxide. J. Biol. Chem. 276:2001;22397-22403
15. 2-terminal kinase-dependent, p53-independent pathway. Cancer Res. 59:1999;3053-3058
16. Huang X. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat. Res. 533:2003;153-171
17. Huang X., Dai J., Fournier J., Ali A.M., Zhang Q., Frenkel K. Ferrous ion autoxidation and its chelation in iron-loaded human liver HepG2 cells. Free Radic. Biol. Med. 32:2002;84-92
18. Jacobs A. Low molecular weight intracellular iron transport compounds. Blood. 50:1977;433-439
19. Kelly, K., Chu, Y., 2000. The regulation of MAP kinase pathways by MAP kinase phosphatases. In: Gutkind, J.S. (Ed.), Signaling Networks and Cell Cycle Control. Human Press, Totowa, pp. 165-182.
20. Lesnefsky E.J. Tissue iron overload and mechanisms of iron-catalyzed oxidative injury. Adv. Exp. Med. Biol. 366:1994;129-146
21. Link G., Konijn A.M., Breuer W., Cabantchik Z.I., Hershko C. Exploring the "iron shuttle" hypothesis in chelation therapy: effects of combined deferoxamine and deferiprone treatment in hypertransfused rats with labeled iron stores and in iron-loaded rat heart cells in culture. J. Lab. Clin. Med. 138:2001;130-138
22. Neufeld, D.D., 1997. Isolation of rat liver Hepatocytes. In: Pollards, J.W., Walkker, J.M. (Eds.), Methods in Basic Cell Culture Protocols. Humana Press, New York, pp. 145-151.
23. Niederau C., Fischer R., Sonnenberg A., Stremmel W., Trampisch H.J., Strohmeyer G. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N. Engl. J. Med. 313:1985;1256-1262
24. Pietrangelo A. Iron, oxidative stress and liver fibrogenesis. J. Hepatol. 28:1998;8-13
25. Pietrangelo A. Physiology of iron transport and the hemochromatosis gene. Am. J. Physiol. Gastrointest. Liver Physiol. 282:2002;G403-G414
26. Poli G., Parola M. Oxidative damage and fibrogenesis. Free Radic. Biol. Med. 22:1997;287-305
27. Porter J.B. A risk-benefit assessment of iron-chelation therapy. Drug Saf. 17:1997;407-421
28. Qian S.Y., Buettner G.R. Iron and dioxygen chemistry is an important route to initiation of biological free radical oxidations: an electron paramagnetic resonance spin trapping study. Free Radic. Biol. Med. 26:1999;1447-1456
29. Rola-Pleszczynski M., Stankova J. Leukotriene B4 enhances interleukin-6 (IL-6) production and IL-6 messenger RNA accumulation in human monocytes in vitro: transcriptional and posttranscriptional mechanisms. Blood. 80:1992;1004-1011
30. Ryan T.P., Aust S.D. The role of iron in oxygen-mediated toxicities. Crit. Rev. Toxicol. 22:1992;119-141
31. Sanceau J., Kaisho T., Hirano T., Wietzerbin J. Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors. J. Biol. Chem. 270:1995;27920-27931
32. Sheth S., Brittenham G.M. Genetic disorders affecting proteins of iron metabolism: clinical implications. Annu. Rev. Med. 51:2000;443-464
33. Smart D.E., Vincent K.J., Arthur M.J., Eickelberg O., Castellazzi M., Mann J., Mann D.A. JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells. J. Biol. Chem. 276:2001;24414-24421
34. Toyokuni S. Iron-induced carcinogenesis: the role of redox regulation. Free Radic. Biol. Med. 20:1996;553-566
35. Watts R.G., Huang C., Young M.R., Li J.J., Dong Z., Pennie W.D., Colburn N.H. Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation. Oncogene. 17:1998;3493-3498
36. Welch K.D., Davis T.Z., Van Eden M.E., Aust S.D. Deleterious iron-mediated oxidation of biomolecules(1) (6). Free Radic. Biol. Med. 32:2002;577-583
37. Zhang Q., Dai J., Ali A., Chen L., Huang X. Roles of bioavailable iron and calcium in coal dust-induced oxidative stress: possible implications in coal workers' lung disease. Free Radic. Res. 36:2002;285-294